Key clinical point: Once-weekly teriparatide improves bone mineral density in osteoporosis.
Major finding: Lumbar spine bone mineral density increased 6.1% after 72 weeks of once-weekly teriparatide.
Study details: A postmarketing observational study in 3,573 people with osteoporosis.
Disclosures: Asahi Kasei Pharma sponsored the study. All authors of the study were employees of the company.
Ifuku E et al. Osteoporos Sarcopenia. 2019 Jun 26. doi: 10.1016/j.afos.2019.06.002.